samedan logo
 
 
spacer
home > pmps > summer 2002 > drying technology - soft capsule manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Drying Technology - Soft Capsule Manufacturing

Soft and Hard Capsules

The manufacturing of hard and soft gelatine capsules is an exacting operation that requires specific conditions to ensure the highest quality of the final product. Some of the many variables that must be dealt with include: gelatine concentration and viscosity; air temperature and humidity; lubrication of pins; stripping and cutting of capsules; inspection and sorting. When the ideal combination of all these factors is met, an acceptable, good quality capsule is produced.
Among these specific variables, manufacturers must deal with air, specifically in terms of temperature and humidity. Proper humidity control is essential during the manufacturing and drying of hard and soft capsules. Air goes directly onto the product and the quality and relative humidity of the air is extremely important.

It is essential to maintain the humidity as closely as possible to the required space conditions with very little variation, as variation in the humidity can cause a variety of problems. Under high humidity conditions, gelatine capsules do not dry properly; in an atmosphere that is too dry, they become hard and brittle. Ideal conditions are consistent humidity and temperature control.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Ing. Koen Egberts, International Sales Manager for Kathabar Systems Ing. Koen Egberts studied mechanical engineering at the High Technical School in Utrecht. After completing his degree he worked for several years at Asea Brown Boveri (ABB). He was responsible for the engineering and sales of the ABB Flдkt climate control systems.
Since 1998 he has held the position of International Sales Manager for Kathabar Systems Europe, a division of Imtech.

spacer
Ing. Koen Egberts
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Eurofins enhances clinical and COVID-19 testing offering in Japan through acquisition of Genetic Lab Co.,Ltd.

Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and a leader in clinical diagnostics testing, announces a share purchase agreement with Transgenic Inc. (2342:JP, Tokyo stock exchange) to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology based testing provider for diagnostics, biomarker development and drug discovery.
More info >>

White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement